Journal of Cancer Therapy

Vol.8 No.11(2017), Paper ID 80183, 11 pages

DOI:10.4236/jct.2017.811080

 

Medical Costs by Disease Stage in Medicare Patients with Metastatic Melanoma

 

Amanda M. Farr, Zhongyun Zhao, Xue Song, Beth Barber, Boris Ivanov, Marilyn Novich

 

Life Sciences, Truven Health Analytics, IBM Company, Cambridge, MA, USA
Global Health Economics, Amgen Inc., Thousand Oaks, CA, USA
Life Sciences, Truven Health Analytics, IBM Company, Cambridge, MA, USA
Global Health Economics, Amgen Inc., Thousand Oaks, CA, USA
Life Sciences, Truven Health Analytics, IBM Company, Cambridge, MA, USA
Life Sciences, Truven Health Analytics, IBM Company, Cambridge, MA, USA

 

Copyright © 2017 Amanda M. Farr, Zhongyun Zhao, Xue Song, Beth Barber, Boris Ivanov, Marilyn Novich et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Farr, A. , Zhao, Z. , Song, X. , Barber, B. , Ivanov, B. and Novich, M. (2017) Medical Costs by Disease Stage in Medicare Patients with Metastatic Melanoma. Journal of Cancer Therapy, 8, 913-923. doi: 10.4236/jct.2017.811080.

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.